Health
Neanderthal-derived protein may reduce the severity of COVID-19 – Medical Xpress
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced…
Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes. The findings are published today in Nature Medicine.
“Our analysis shows evidence that OAS1 has a protective effect against COVID-19 susceptibility and severity,” explains…
-
Noosa News20 hours agoBrisbane’s original 1979 electric trains take one last journey
-
Noosa News12 hours agoRainbow Beach surfer’s untold 7/7 story
-
General18 hours agoParis opens River Seine for public swimming for first time since 1923
-
Noosa News10 hours agoInfluenza cases nearly 20 per cent higher than 2024 as Queensland faces one of its worst flu seasons in years